Medi Assist Healthcare Services Limited (BOM:544088)
404.25
-12.30 (-2.95%)
At close: Feb 13, 2026
BOM:544088 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 8,517 | 7,233 | 6,347 | 5,049 | 3,938 | 3,227 |
Revenue Growth (YoY) | 21.45% | 13.96% | 25.70% | 28.22% | 22.02% | 1.30% |
Cost of Revenue | 3,857 | 3,239 | 2,744 | 2,136 | 1,696 | 1,514 |
Gross Profit | 4,660 | 3,994 | 3,603 | 2,914 | 2,242 | 1,713 |
Selling, General & Admin | 370.98 | 370.98 | 287.73 | 198.11 | 88.91 | 21.37 |
Other Operating Expenses | 2,605 | 2,069 | 1,979 | 1,515 | 1,232 | 872.9 |
Operating Expenses | 3,679 | 2,998 | 2,698 | 1,981 | 1,605 | 1,271 |
Operating Income | 981.22 | 996.41 | 904.94 | 932.5 | 637.49 | 442.19 |
Interest Expense | -248.82 | -100.59 | -31.2 | -29.25 | -28.71 | -56.74 |
Interest & Investment Income | 120.8 | 120.8 | 108.28 | 41.68 | 31.29 | 130.34 |
Currency Exchange Gain (Loss) | -7.98 | -7.98 | -2.64 | -1.97 | - | - |
Other Non Operating Income (Expenses) | 29.29 | 16.84 | 48.54 | 14.8 | 21.66 | 27.54 |
EBT Excluding Unusual Items | 874.51 | 1,025 | 1,028 | 957.76 | 661.73 | 543.33 |
Gain (Loss) on Sale of Investments | 96.1 | 96.1 | 22.39 | 72.76 | 58.69 | 67.08 |
Gain (Loss) on Sale of Assets | - | - | - | -4.76 | 60.33 | - |
Asset Writedown | -2.64 | -2.64 | - | - | - | - |
Other Unusual Items | -143.02 | -1.07 | -206.44 | 10.33 | 26.11 | - |
Pretax Income | 824.95 | 1,118 | 843.87 | 1,036 | 806.86 | 610.41 |
Income Tax Expense | 260.28 | 201.86 | 130.92 | 283.01 | 172.2 | 230.35 |
Earnings From Continuing Operations | 564.67 | 916.01 | 712.95 | 753.08 | 634.66 | 380.06 |
Earnings From Discontinued Operations | -0.45 | -0.83 | -21.13 | -12.66 | 7.51 | -117.31 |
Net Income to Company | 564.22 | 915.18 | 691.82 | 740.42 | 642.17 | 262.75 |
Minority Interest in Earnings | -4.18 | -6.39 | -22.43 | 0.17 | - | - |
Net Income | 560.04 | 908.79 | 669.39 | 740.59 | 642.17 | 262.75 |
Net Income to Common | 560.04 | 908.79 | 669.39 | 740.59 | 642.17 | 262.75 |
Net Income Growth | -40.73% | 35.76% | -9.61% | 15.33% | 144.40% | -21.68% |
Shares Outstanding (Basic) | 71 | 70 | 69 | 69 | 69 | 67 |
Shares Outstanding (Diluted) | 72 | 71 | 70 | 70 | 69 | 68 |
Shares Change (YoY) | 0.60% | 0.83% | 0.95% | 0.18% | 2.60% | 0.38% |
EPS (Basic) | 7.84 | 12.91 | 9.71 | 10.76 | 9.33 | 3.92 |
EPS (Diluted) | 7.84 | 12.85 | 9.54 | 10.65 | 9.25 | 3.89 |
EPS Growth | -41.03% | 34.69% | -10.41% | 15.14% | 137.99% | -21.92% |
Free Cash Flow | - | 922.93 | 479.59 | 534.1 | 583.93 | 1,275 |
Free Cash Flow Per Share | - | 13.04 | 6.83 | 7.68 | 8.41 | 18.84 |
Dividend Per Share | - | - | 4.000 | 1.890 | 1.890 | 2.500 |
Dividend Growth | - | - | 111.64% | - | -24.40% | - |
Gross Margin | 54.72% | 55.22% | 56.76% | 57.70% | 56.93% | 53.09% |
Operating Margin | 11.52% | 13.78% | 14.26% | 18.47% | 16.19% | 13.70% |
Profit Margin | 6.58% | 12.56% | 10.55% | 14.67% | 16.31% | 8.14% |
Free Cash Flow Margin | - | 12.76% | 7.56% | 10.58% | 14.83% | 39.50% |
EBITDA | 1,263 | 1,253 | 1,129 | 1,068 | 786.31 | 592.84 |
EBITDA Margin | 14.83% | 17.33% | 17.79% | 21.16% | 19.97% | 18.37% |
D&A For EBITDA | 281.47 | 257.05 | 224.49 | 135.97 | 148.82 | 150.65 |
EBIT | 981.22 | 996.41 | 904.94 | 932.5 | 637.49 | 442.19 |
EBIT Margin | 11.52% | 13.78% | 14.26% | 18.47% | 16.19% | 13.70% |
Effective Tax Rate | 31.55% | 18.06% | 15.51% | 27.32% | 21.34% | 37.74% |
Revenue as Reported | 8,767 | 7,471 | 6,530 | 5,190 | 4,120 | 3,453 |
Advertising Expenses | - | 311.98 | 238.41 | 185.58 | 72.62 | 21.25 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.